PMCPA Case
| Case number | AUTH/2430/8/11 |
| Parties | GlaxoSmithKline Consumer Healthcare v Johnson & Johnson Limited |
| Product | Nicorette QuickMist (nicotine mouthspray) |
| Material | Prescriber mailing (ref 06458) |
| Main issues | Implied claim that “60 second craving relief” applied to “breakthrough cravings”; misleading cost-per-day claim due to dosing and pack/price presentation |
| Key claims challenged | “60 second craving relief”; “Breakthrough cravings can jeopardise a quit attempt”; “Cost of treatment: £1.23 per day for an average 20 per day smoker, using one spray in place of their normal cigarette**” (**Based on the NHS cost of the duo pack) |
| Panel findings | Misleading by juxtaposition/terminology ambiguity; cost claim misleading (two-spray study not made clear; single pack image vs duo pack cost basis; footnote insufficient) |
| Breach clauses | Clause 7.2 (x2) |
| Sanctions | Undertaking received; Additional sanctions: Not stated |
| Complaint received | 08 August 2011 |
| Case completed | 15 September 2011 |
| Appeal | No appeal |
| Applicable Code year | 2011 |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.